Immuno Oncology Assays Market Size, Share, And Growth Report 2032
Immuno Oncology Assays Market by Product (Consumables and Software), by Assay (Cell Migration & Invasion, Cell Proliferation, Immune Cell Killing, Phagocytosis, and Others), by Technology (PCR, Immunoassay, NGS, Flow Cytometry, and Others), by Indication (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Other Cancers), by Application (Clinical Diagnostics and Research Applications), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.15 Billion | USD 12.74 Billion | 10.6% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Immuno Oncology Assays Market Revenue, 2016-2025 (USD Million)
- 2.2. Global Immuno Oncology Assays Market: Snapshot
- Chapter 3. Immuno Oncology Assays Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Immuno Oncology Assays Market drivers: Impact analysis
- 3.2.2. Increasing Prevalence of Cancer
- 3.2.3. Rising adoption of targeted therapy
- 3.3. Market Restraints
- 3.3.1. High capital investments
- 3.4. Opportunities
- 3.4.1. Emerging markets
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Product
- 3.6.2. Market attractiveness analysis, by Assay
- 3.6.3. Market attractiveness analysis, by Technology
- 3.6.4. Market attractiveness analysis, by Indication
- 3.6.5. Market attractiveness analysis, by Application
- 3.6.6. Market attractiveness analysis, by Region
- Chapter 4. Global Immuno Oncology Assays Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Immuno Oncology Assays Market: Company Market Share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Immuno Oncology Assays Market - Product Analysis
- 5.1. Global Immuno Oncology Assays Market: Product overview
- 5.1.1. Global Immuno Oncology Assays Market revenue share, by Product, 2018 and 2025
- 5.2. Consumables
- 5.2.1. Global Immuno Oncology Assays Market for Consumables, 2016-2025 (USD Million)
- 5.3. Software
- 5.3.1. Global Immuno Oncology Assays Market for Software, 2016-2025 (USD Million)
- 5.1. Global Immuno Oncology Assays Market: Product overview
- Chapter 6. Global Immuno Oncology Assays Market - Assay Analysis
- 6.1. Global Immuno Oncology Assays Market: Assay overview
- 6.1.1. Global Immuno Oncology Assays Market revenue share, by Assay, 2018 and 2025
- 6.2. Cell Proliferation
- 6.2.1. Global Immuno Oncology Assays Market for Cell Proliferation, 2016-2025 (USD Million)
- 6.3. Cell Migration & Invasion
- 6.3.1. Global Immuno Oncology Assays Market for Cell Migration & Invasion, 2016-2025 (USD Million)
- 6.4. Phagocytosis
- 6.4.1. Global Immuno Oncology Assays Market for Phagocytosis, 2016-2025 (USD Million)
- 6.5. Immune Cell Killing
- 6.5.1. Global Immuno Oncology Assays Market for Immune Cell Killing, 2016-2025 (USD Million)
- 6.6. Others
- 6.6.1. Global Immuno Oncology Assays Market for Others, 2016-2025 (USD Million)
- 6.1. Global Immuno Oncology Assays Market: Assay overview
- Chapter 7. Global Immuno Oncology Assays Market - Technology Analysis
- 7.1. Global Immuno Oncology Assays Market: Technology overview
- 7.1.1. Global Immuno Oncology Assays Market revenue share, by Technology, 2018 and 2025
- 7.2. PCR
- 7.2.1. Global Immuno Oncology Assays Market for PCR, 2016-2025 (USD Million)
- 7.3. Immunoassay
- 7.3.1. Global Immuno Oncology Assays Market for Immunoassay, 2016-2025 (USD Million)
- 7.4. NGS
- 7.4.1. Global Immuno Oncology Assays Market for NGS, 2016-2025 (USD Million)
- 7.5. Flow Cytometry
- 7.5.1. Global Immuno Oncology Assays Market for Flow Cytometry, 2016-2025 (USD Million)
- 7.6. Others
- 7.6.1. Global Immuno Oncology Assays Market for Others, 2016-2025 (USD Million)
- 7.1. Global Immuno Oncology Assays Market: Technology overview
- Chapter 8. Global Immuno Oncology Assays Market - Indication Analysis
- 8.1. Global Immuno Oncology Assays Market: Indication overview
- 8.1.1. Global Immuno Oncology Assays Market revenue share, by Indication, 2018 and 2025
- 8.2. Lung Cancer
- 8.2.1. Global Immuno Oncology Assays Market for Lung Cancer, 2016-2025 (USD Million)
- 8.3. Colorectal Cancer
- 8.3.1. Global Immuno Oncology Assays Market for Colorectal Cancer, 2016-2025 (USD Million)
- 8.4. Melanoma
- 8.4.1. Global Immuno Oncology Assays Market for Melanoma, 2016-2025 (USD Million)
- 8.5. Bladder Cancer
- 8.5.1. Global Immuno Oncology Assays Market for Bladder Cancer, 2016-2025 (USD Million)
- 8.6. Other Cancers
- 8.6.1. Global Immuno Oncology Assays Market for Other Cancers, 2016-2025 (USD Million)
- 8.1. Global Immuno Oncology Assays Market: Indication overview
- Chapter 9. Global Immuno Oncology Assays Market - Application Analysis
- 9.1. Global Immuno Oncology Assays Market: Application overview
- 9.1.1. Global Immuno Oncology Assays Market revenue share, by Application, 2018 and 2025
- 9.2. Research Applications
- 9.2.1. Global Immuno Oncology Assays Market for Research Applications, 2016-2025 (USD Million)
- 9.3. Clinical Diagnostics
- 9.3.1. Global Immuno Oncology Assays Market for Clinical Diagnostics, 2016-2025 (USD Million)
- 9.1. Global Immuno Oncology Assays Market: Application overview
- Chapter 10. Global Immuno Oncology Assays Market - Regional Analysis
- 10.1. Global Immuno Oncology Assays Market: Regional overview
- 10.1.1. Global Immuno Oncology Assays Market revenue share, by region, 2018 and 2025
- 10.2. North America
- 10.2.1. North America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.2.2. North America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.2.3. North America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.2.4. North America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.2.5. North America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.2.6. The U.S.
- 10.2.6.1. The U.S. Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.2.6.2. The U.S. Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.2.6.3. The U.S. Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.2.6.4. The U.S. Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.2.6.5. The U.S. Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.2.7. Rest of North America
- 10.2.7.1. Rest of North America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.2.7.2. Rest of North America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.2.7.3. Rest of North America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.2.7.4. Rest of North America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.2.7.5. Rest of North America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.3. Europe
- 10.3.1. Europe Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.3.2. Europe Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.3.3. Europe Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.3.4. Europe Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.3.5. Europe Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.3.6. Germany
- 10.3.6.1. Germany Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.3.6.2. Germany Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.3.6.3. Germany Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.3.6.4. Germany Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.3.6.5. Germany Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.3.7. U.K.
- 10.3.7.1. U.K. Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.3.7.2. U.K. Immuno Oncology Assays MarketRevenue, by Assay, 2016-2025 (USD Million)
- 10.3.7.3. U.K. Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.3.7.4. U.K. Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.3.7.5. U.K. Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.3.8. France
- 10.3.8.1. France Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.3.8.2. France Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.3.8.3. France Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.3.8.4. France Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.3.8.5. France Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.3.9. Rest of Europe
- 10.3.9.1. Rest of Europe Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.3.9.2. Rest of Europe Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.3.9.3. Rest of Europe Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.3.9.4. Rest of Europe Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.3.9.5. Rest of Europe Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.4. Asia Pacific
- 10.4.1. Asia Pacific Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.4.2. Asia Pacific Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.4.3. Asia Pacific Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.4.4. Asia Pacific Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.4.5. Asia Pacific Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.4.6. China
- 10.4.6.1. China Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.4.6.2. China Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.4.6.3. China Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.4.6.4. China Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.4.6.5. China Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.4.7. Japan
- 10.4.7.1. Japan Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.4.7.2. Japan Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.4.7.3. Japan Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.4.7.4. Japan Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.4.7.5. Japan Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.4.8. India
- 10.4.8.1. India Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.4.8.2. India Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.4.8.3. India Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.4.8.4. India Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.4.8.5. India Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.4.9. Rest of Asia Pacific
- 10.4.9.1. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.4.9.2. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.4.9.3. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.4.9.4. Rest of Asia Pacific Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.4.9.5. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.5. Latin America
- 10.5.1. Latin America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.5.2. Latin America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.5.3. Latin America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.5.4. Latin America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.5.5. Latin America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.5.6. Brazil
- 10.5.6.1. Brazil Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.5.6.2. Brazil Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.5.6.3. Brazil Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.5.6.4. Brazil Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.5.6.5. Brazil Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.5.7. Rest of Latin America
- 10.5.7.1. Rest of Latin America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.5.7.2. Rest of Latin America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.5.7.3. Rest of Latin America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.5.7.4. Rest of Latin America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.5.7.5. Rest of Latin America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.6. The Middle East and Africa
- 10.6.1. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
- 10.6.2. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
- 10.6.3. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
- 10.6.4. The Middle East and Africa Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
- 10.6.5. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
- 10.1. Global Immuno Oncology Assays Market: Regional overview
- Chapter 11. Company Profile
- 11.1. Thermo Fisher Scientific
- 11.1.1. Overview
- 11.1.2. Financials
- 11.1.3. Product Portfolio
- 11.1.4. Business strategy
- 11.1.5. Recent developments
- 11.2. Agilent Technologies
- 11.2.1. Overview
- 11.2.2. Financials
- 11.2.3. Product Portfolio
- 11.2.4. Business strategy
- 11.2.5. Recent developments
- 11.3. Roche Diagnostics
- 11.3.1. Overview
- 11.3.2. Financials
- 11.3.3. Product Portfolio
- 11.3.4. Business strategy
- 11.3.5. Recent developments
- 11.4. Nanostring Technologies
- 11.4.1. Overview
- 11.4.2. Financials
- 11.4.3. Product Portfolio
- 11.4.4. Business strategy
- 11.4.5. Recent developments
- 11.5. Illumina
- 11.5.1. Overview
- 11.5.2. Financials
- 11.5.3. Product Portfolio
- 11.5.4. Business strategy
- 11.5.5. Recent developments
- 11.6. Foundation Medicine
- 11.6.1. Overview
- 11.6.2. Financials
- 11.6.3. Product Portfolio
- 11.6.4. Business strategy
- 11.6.5. Recent developments
- 11.7. Sartorius
- 11.7.1. Overview
- 11.7.2. Financials
- 11.7.3. Product Portfolio
- 11.7.4. Business strategy
- 11.7.5. Recent developments
- 11.8. Qiagen
- 11.8.1. Overview
- 11.8.2. Financials
- 11.8.3. Product Portfolio
- 11.8.4. Business strategy
- 11.8.5. Recent developments
- 11.9. HTG Molecular Diagnostics
- 11.9.1. Overview
- 11.9.2. Financials
- 11.9.3. Product Portfolio
- 11.9.4. Business strategy
- 11.9.5. Recent developments
- 11.10. PerkinElmer
- 11.10.1. Overview
- 11.10.2. Financials
- 11.10.3. Product Portfolio
- 11.10.4. Business strategy
- 11.10.5. Recent developments
- 11.11. Merck
- 11.11.1. Overview
- 11.11.2. Financials
- 11.11.3. Product Portfolio
- 11.11.4. Business strategy
- 11.11.5. Recent developments
- 11.1. Thermo Fisher Scientific
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Immuno Oncology Assays Market revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Immuno Oncology Assays Market attractiveness analysis, by Product
6. Immuno Oncology Assays Market attractiveness analysis, by Assay
7. Immuno Oncology Assays Market attractiveness analysis, by Technology
8. Immuno Oncology Assays Market attractiveness analysis, by Indication
9. Immuno Oncology Assays Market attractiveness analysis, by Application
10. Immuno Oncology Assays Market attractiveness analysis, by Region
11. Company market share analysis, 2018
12. Global Immuno Oncology Assays Market revenue share by Product, 2018 and 2025
13. Global Immuno Oncology Assays Market Revenue for Consumables, 2016–2025 (USD Million)
14. Global Immuno Oncology Assays Market Revenue for Software, 2016–2025 (USD Million)
15. Global Immuno Oncology Assays Market revenue share by Assay, 2018 and 2025
16. Global Immuno Oncology Assays Market Revenue for Cell Proliferation, 2016–2025 (USD Million)
17. Global Immuno Oncology Assays Market Revenue for Cell Migration & Invasion, 2016–2025 (USD Million)
18. Global Immuno Oncology Assays Market Revenue for Phagocytosis, 2016–2025 (USD Million)
19. Global Immuno Oncology Assays Market Revenue for Immune Cell Killing, 2016–2025 (USD Million)
20. Global Immuno Oncology Assays Market Revenue for Others, 2016–2025 (USD Million)
21. Global Immuno Oncology Assays Market revenue share by Technology, 2018 and 2025
22. Global Immuno Oncology Assays Market Revenue for PCR, 2016–2025 (USD Million)
23. Global Immuno Oncology Assays Market Revenue for Immunoassay, 2016–2025 (USD Million)
24. Global Immuno Oncology Assays Market Revenue for NGS, 2016–2025 (USD Million)
25. Global Immuno Oncology Assays Market Revenue for Flow Cytometry, 2016–2025 (USD Million)
26. Global Immuno Oncology Assays Market Revenue for Others, 2016–2025 (USD Million)
27. Global Immuno Oncology Assays Market revenue share by Indication, 2018 and 2025
28. Global Immuno Oncology Assays Market Revenue for Lung Cancer, 2016–2025 (USD Million)
29. Global Immuno Oncology Assays Market Revenue for Colorectal Cancer, 2016–2025 (USD Million)
30. Global Immuno Oncology Assays Market Revenue for Melanoma, 2016–2025 (USD Million)
31. Global Immuno Oncology Assays Market Revenue for Bladder Cancer, 2016–2025 (USD Million)
32. Global Immuno Oncology Assays Market Revenue for Other Cancers, 2016–2025 (USD Million)
33. Global Immuno Oncology Assays Market revenue share by Application, 2018 and 2025
34. Global Immuno Oncology Assays Market Revenue for Research Applications, 2016–2025 (USD Million)
35. Global Immuno Oncology Assays Market Revenue for Clinical Diagnostics, 2016–2025 (USD Million)
36. North America Immuno Oncology Assays Market Revenue, 2016–2025 (USD Million)
37. Europe Immuno Oncology Assays Market Revenue, 2016–2025 (USD Million)
38. Asia Pacific Immuno Oncology Assays Market Revenue, 2016–2025 (USD Million)
39. Latin America Immuno Oncology Assays Market Revenue, 2016–2025 (USD Million)
40. The Middle East and Africa Immuno Oncology Assays Market Revenue, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Immuno Oncology Assays Market: Market Snapshot
2. Drivers of the Global Immuno Oncology Assays Market: Impact analysis
3. Restraints of the Global Immuno Oncology Assays Market: Impact analysis
4. North America Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
5. North America Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
6. North America Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
7. North America Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
8. North America Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
9. The U.S. Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
10. The U.S. Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
11. The U.S. Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
12. The U.S. Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
13. The U.S. Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
14. Rest of North America Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
15. Rest of North America Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
16. Rest of North America Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
17. Rest of North America Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
18. Rest of North America Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
19. Europe Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
20. Europe Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
21. Europe Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
22. Europe Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
23. Europe Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
24. Germany Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
25. Germany Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
26. Germany Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
27. Germany Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
28. Germany Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
29. U.K. Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
30. U.K. Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
31. U.K. Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
32. U.K. Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
33. U.K. Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
34. France Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
35. France Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
36. France Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
37. France Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
38. France Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
39. Rest of Europe Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
40. Rest of Europe Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
41. Rest of Europe Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
42. Rest of Europe Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
43. Rest of Europe Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
44. Asia Pacific Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
45. Asia Pacific Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
46. Asia Pacific Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
47. Asia Pacific Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
48. Asia Pacific Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
49. China Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
50. China Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
51. China Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
52. China Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
53. China Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
54. Japan Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
55. Japan Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
56. Japan Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
57. Japan Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
58. Japan Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
59. India Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
60. India Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
61. India Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
62. India Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
63. India Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
64. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
65. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
66. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
67. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
68. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
69. Latin America Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
70. Latin America Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
71. Latin America Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
72. Latin America Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
73. Latin America Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
74. Brazil Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
75. Brazil Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
76. Brazil Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
77. Brazil Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
78. Brazil Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
79. Rest of Latin America Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
80. Rest of Latin America Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
81. Rest of Latin America Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
82. Rest of Latin America Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
83. Rest of Latin America Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
84. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Product, 2016–2025 (USD Million)
85. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Assay, 2016–2025 (USD Million)
86. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Technology, 2016–2025 (USD Million)
87. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Indication, 2016–2025 (USD Million)
88. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Application, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Immuno-oncology deals with investigating the body’s immune system in response to cancer cells. Immuno-oncology assays are in-vitro assays that are used to study a drug’s or compound’s response in a tumor’s microenvironment.
According to study, the Immuno Oncology Assays Market size was worth around USD 5.15 billion in 2023 and is predicted to grow to around USD 12.74 billion by 2032.
The CAGR value of Immuno Oncology Assays Market is expected to be around 10.6% during 2024-2032.
North America has been leading the Immuno Oncology Assays Market and is anticipated to continue on the dominant position in the years to come.
The Immuno Oncology Assays Market is led by players like Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.
HappyClients
